{"id":511087,"date":"2021-07-08T16:08:04","date_gmt":"2021-07-08T20:08:04","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-present-at-the-virtual-william-blair-biotech-focus-conference-on-july-15-2021\/"},"modified":"2021-07-08T16:08:04","modified_gmt":"2021-07-08T20:08:04","slug":"exelixis-to-present-at-the-virtual-william-blair-biotech-focus-conference-on-july-15-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-present-at-the-virtual-william-blair-biotech-focus-conference-on-july-15-2021\/","title":{"rendered":"Exelixis to Present at the Virtual William Blair Biotech Focus Conference on July 15, 2021"},"content":{"rendered":"

<\/p>\n

Exelixis to Present at the Virtual William Blair Biotech Focus Conference on July 15, 2021<\/b><\/p>\n

\u2013<\/i> Presentation to be webcast on www.exelixis.com<\/a><\/i>\u2013<\/i><\/p>\n

ALAMEDA, Calif.–(BUSINESS WIRE<\/a>)–
\nExelixis, Inc. (Nasdaq: EXEL) today announced that Peter Lamb, Ph.D., the company\u2019s Executive Vice President, Scientific Strategy and Chief Scientific Officer, will present at the virtual William Blair Biotech Focus Conference 2021 on Thursday, July 15th<\/sup> at 2:00 p.m. EDT \/ 1:00 p.m. CDT \/ 11:00 a.m. PDT.\n<\/p>\n

\nTo access the webcast link, log onto www.exelixis.com<\/a> and proceed to the News & Events \/ Event Calendar page under the Investors & Media heading. Please connect to the company\u2019s website at least 15 minutes prior to the presentation to ensure adequate time for any software download that may be required to listen to the webcast. A replay will also be available at the same location for 14 days.\n<\/p>\n

About Exelixis<\/b><\/p>\n

\nFounded in 1994, Exelixis, Inc. (Nasdaq: EXEL) is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines for difficult-to-treat cancers. Following early work in model system genetics, we established a broad drug discovery and development platform that has served as the foundation for our continued efforts to bring new cancer therapies to patients in need. Our discovery efforts have resulted in four commercially available products, CABOMETYX\u00ae<\/sup> (cabozantinib), COMETRIQ\u00ae<\/sup> (cabozantinib), COTELLIC\u00ae<\/sup> (cobimetinib) and MINNEBRO\u00ae<\/sup> (esaxerenone), and we have entered into partnerships with leading pharmaceutical companies to bring these important medicines to patients worldwide. Supported by revenues from our marketed products and collaborations, we are committed to prudently reinvesting in our business to maximize the potential of our pipeline. We are supplementing our existing therapeutic assets with targeted business development activities and internal drug discovery \u2013 all to deliver the next generation of Exelixis medicines and help patients recover stronger and live longer. Exelixis is a member of the Standard & Poor\u2019s (S&P) MidCap 400 index, which measures the performance of profitable mid-sized companies. In November 2020, the company was named to Fortune<\/i>\u2019s 100 Fastest-Growing Companies list for the first time, ranking 17th<\/sup> overall and the third-highest biopharmaceutical company. For more information about Exelixis, please visit www.exelixis.com<\/a>, follow @ExelixisInc<\/a> on Twitter or like Exelixis, Inc.<\/a> on Facebook.\n<\/p>\n

Exelixis, the Exelixis logo, CABOMETYX, COMETRIQ and COTELLIC are registered trademarks of Exelixis, Inc. MINNEBRO is a registered trademark of Daiichi Sankyo Company, Limited.<\/i><\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210708005288\/en\/<\/a><\/span><\/p>\n

Investors Contact:
\n<\/b>
Varant Shirvanian
\n<\/i>
Sr. Investor Relations Manager
\n<\/i>
Exelixis, Inc.
\n<\/i>
650-837-7917
\n<\/i>
vshirvanian@exelixis.com<\/i><\/a><\/p>\n

Media Contact:
\n<\/b>
Hal Mackins
\n<\/i>
For Exelixis, Inc.
\n<\/i>
415-994-0040
\n<\/i>
hal@torchcommunications.com<\/a><\/i><\/p>\n

KEYWORDS:<\/b> California United States North America<\/p>\n

INDUSTRY KEYWORDS:<\/b> Oncology Health Other Health General Health Pharmaceutical Biotechnology<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Exelixis to Present at the Virtual William Blair Biotech Focus Conference on July 15, 2021 \u2013 Presentation to be webcast on www.exelixis.com\u2013 ALAMEDA, Calif.–(BUSINESS WIRE)– Exelixis, Inc. (Nasdaq: EXEL) today announced that Peter Lamb, Ph.D., the company\u2019s Executive Vice President, Scientific Strategy and Chief Scientific Officer, will present at the virtual William Blair Biotech Focus Conference 2021 on Thursday, July 15th at 2:00 p.m. EDT \/ 1:00 p.m. CDT \/ 11:00 a.m. PDT. To access the webcast link, log onto www.exelixis.com and proceed to the News & Events \/ Event Calendar page under the Investors & Media heading. Please connect to the company\u2019s website at least 15 minutes prior to the presentation to ensure adequate time for any software download … <\/p>\n

Continue reading “Exelixis to Present at the Virtual William Blair Biotech Focus Conference on July 15, 2021”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-511087","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nExelixis to Present at the Virtual William Blair Biotech Focus Conference on July 15, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-present-at-the-virtual-william-blair-biotech-focus-conference-on-july-15-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Exelixis to Present at the Virtual William Blair Biotech Focus Conference on July 15, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Exelixis to Present at the Virtual William Blair Biotech Focus Conference on July 15, 2021 \u2013 Presentation to be webcast on www.exelixis.com\u2013 ALAMEDA, Calif.–(BUSINESS WIRE)– Exelixis, Inc. (Nasdaq: EXEL) today announced that Peter Lamb, Ph.D., the company\u2019s Executive Vice President, Scientific Strategy and Chief Scientific Officer, will present at the virtual William Blair Biotech Focus Conference 2021 on Thursday, July 15th at 2:00 p.m. EDT \/ 1:00 p.m. CDT \/ 11:00 a.m. PDT. To access the webcast link, log onto www.exelixis.com and proceed to the News & Events \/ Event Calendar page under the Investors & Media heading. Please connect to the company\u2019s website at least 15 minutes prior to the presentation to ensure adequate time for any software download … Continue reading "Exelixis to Present at the Virtual William Blair Biotech Focus Conference on July 15, 2021"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-present-at-the-virtual-william-blair-biotech-focus-conference-on-july-15-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-08T20:08:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210708005288r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exelixis-to-present-at-the-virtual-william-blair-biotech-focus-conference-on-july-15-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exelixis-to-present-at-the-virtual-william-blair-biotech-focus-conference-on-july-15-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Exelixis to Present at the Virtual William Blair Biotech Focus Conference on July 15, 2021\",\"datePublished\":\"2021-07-08T20:08:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exelixis-to-present-at-the-virtual-william-blair-biotech-focus-conference-on-july-15-2021\\\/\"},\"wordCount\":465,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exelixis-to-present-at-the-virtual-william-blair-biotech-focus-conference-on-july-15-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210708005288r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exelixis-to-present-at-the-virtual-william-blair-biotech-focus-conference-on-july-15-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exelixis-to-present-at-the-virtual-william-blair-biotech-focus-conference-on-july-15-2021\\\/\",\"name\":\"Exelixis to Present at the Virtual William Blair Biotech Focus Conference on July 15, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exelixis-to-present-at-the-virtual-william-blair-biotech-focus-conference-on-july-15-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exelixis-to-present-at-the-virtual-william-blair-biotech-focus-conference-on-july-15-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210708005288r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2021-07-08T20:08:04+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exelixis-to-present-at-the-virtual-william-blair-biotech-focus-conference-on-july-15-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exelixis-to-present-at-the-virtual-william-blair-biotech-focus-conference-on-july-15-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exelixis-to-present-at-the-virtual-william-blair-biotech-focus-conference-on-july-15-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210708005288r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210708005288r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exelixis-to-present-at-the-virtual-william-blair-biotech-focus-conference-on-july-15-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Exelixis to Present at the Virtual William Blair Biotech Focus Conference on July 15, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Exelixis to Present at the Virtual William Blair Biotech Focus Conference on July 15, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-present-at-the-virtual-william-blair-biotech-focus-conference-on-july-15-2021\/","og_locale":"en_US","og_type":"article","og_title":"Exelixis to Present at the Virtual William Blair Biotech Focus Conference on July 15, 2021 - Market Newsdesk","og_description":"Exelixis to Present at the Virtual William Blair Biotech Focus Conference on July 15, 2021 \u2013 Presentation to be webcast on www.exelixis.com\u2013 ALAMEDA, Calif.–(BUSINESS WIRE)– Exelixis, Inc. (Nasdaq: EXEL) today announced that Peter Lamb, Ph.D., the company\u2019s Executive Vice President, Scientific Strategy and Chief Scientific Officer, will present at the virtual William Blair Biotech Focus Conference 2021 on Thursday, July 15th at 2:00 p.m. EDT \/ 1:00 p.m. CDT \/ 11:00 a.m. PDT. To access the webcast link, log onto www.exelixis.com and proceed to the News & Events \/ Event Calendar page under the Investors & Media heading. Please connect to the company\u2019s website at least 15 minutes prior to the presentation to ensure adequate time for any software download … Continue reading \"Exelixis to Present at the Virtual William Blair Biotech Focus Conference on July 15, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-present-at-the-virtual-william-blair-biotech-focus-conference-on-july-15-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-08T20:08:04+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210708005288r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-present-at-the-virtual-william-blair-biotech-focus-conference-on-july-15-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-present-at-the-virtual-william-blair-biotech-focus-conference-on-july-15-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Exelixis to Present at the Virtual William Blair Biotech Focus Conference on July 15, 2021","datePublished":"2021-07-08T20:08:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-present-at-the-virtual-william-blair-biotech-focus-conference-on-july-15-2021\/"},"wordCount":465,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-present-at-the-virtual-william-blair-biotech-focus-conference-on-july-15-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210708005288r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-present-at-the-virtual-william-blair-biotech-focus-conference-on-july-15-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-present-at-the-virtual-william-blair-biotech-focus-conference-on-july-15-2021\/","name":"Exelixis to Present at the Virtual William Blair Biotech Focus Conference on July 15, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-present-at-the-virtual-william-blair-biotech-focus-conference-on-july-15-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-present-at-the-virtual-william-blair-biotech-focus-conference-on-july-15-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210708005288r1&sid=flmnd&distro=nx&lang=en","datePublished":"2021-07-08T20:08:04+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-present-at-the-virtual-william-blair-biotech-focus-conference-on-july-15-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-present-at-the-virtual-william-blair-biotech-focus-conference-on-july-15-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-present-at-the-virtual-william-blair-biotech-focus-conference-on-july-15-2021\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210708005288r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210708005288r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-present-at-the-virtual-william-blair-biotech-focus-conference-on-july-15-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Exelixis to Present at the Virtual William Blair Biotech Focus Conference on July 15, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/511087","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=511087"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/511087\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=511087"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=511087"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=511087"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}